European Commission approves sale of first drug for Covid-19 treatment

Source : 112 Ukraine

Currently, 17 coronavirus vaccines are being tested on humans worldwide
19:02, 3 July 2020

Covid-19 drug remdesivir

The European Commission has granted conditional marketing authorization for the anti-viral drug remdesivir, making it the first drug, authorized at the EU level, which is applicable for the treatment of Covid-19. It was reported by with reference to the commission’s statement.

"The protection of public health is a key priority for the Commission, and therefore data on remdesivir have been evaluated in an extremely short time using a rapid review procedure, the approach used by the EMA during health emergencies in order to assess data as they become available," the statement said.

It is worth noting that 17 coronavirus vaccines are currently being tested on humans worldwide.

Related: Covid-19 vaccine development: How long would quarantine stay for?

As we reported earlier, an international group of scientists has discovered a new mutation of coronavirus - G614. It appears to spread faster than the common form of Covid-19.

British professor Lawrence Young assumes that the new version of coronavirus is less pathogenic and patients tend to cope with symptoms easier, and it could be good news.

Related: British drugmaker to deliver 400 million doses of coronavirus vaccine to Europe

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more